EMA collects data via the platform from national competent authorities (NCAs) and marketing authorisation holders (MAHs).
MAHs of centrally authorised products must use the platform to report medicine shortages regularly.
NCAs and MAHs must submit data on the availability, supply, and demand of medicines in situations that require close monitoring (i.e. crises or preparedness actions).
This is in line with EMA's extended mandate, laid out in Regulation (EU) 2022/123.
For more information on the scope of reporting in particular instances, go to the following section on this page:
To access the platform, go to:
To get an overview of the platform, including its scope and objectives consult the informational brief available below:
For more information, see:
Reporting via ESMP
The platform enables EMA to monitor the supply, demand and availability of medicines in three scenarios:
- Under normal circumstances;
- When EMA's Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG), also known as the Medicine Shortages Steering Group, requests this type of reporting. This is often referred to as MSSG-led preparedness;
- When preparing for and reacting to a crisis.
See the table below for more details on who reports what product type in which scenario:
- Normal circumstances
Routine reporting of shortages of medicinal products.
Who needs to report:
- Marketing authorisation holders
When to report:
- When MAHs become aware of a potential or actual shortage of one of their products. MAHs must update EMA with new relevant information through the platform as it becomes available
Product type:
- Centrally authorised products
- MSSG-led preparedness
Close monitoring of specific medicine(s) at the request of EMA's Medicine Shortages Steering Group (MSSG). The group creates a specific list of medicines for each action.
Who needs to report:
- Marketing authorisation holders
- National competent authorities
When to report:
- When MSSG announces a preparedness action, it defines products in scope and the reporting frequency. EMA notifies MAHs with relevant products before reporting starts.
Product type:
- Centrally authorised products
- Nationally authorised products
- Crisis
Reporting on supply, demand and availability of medicinal products during a public health emergency or major event.
EMA publishes a list of critical medicines it monitors for each particular crisis.
Who needs to report:
- Marketing authorisation holders
- National competent authorities
When to report:
- When the European Commission recognises a crisis. MSSG defines products in scope and the reporting frequency. EMA notifies MAHs with products in scope before reporting starts.
Product type:
- Centrally authorised products
- Nationally authorised products
How to access platform
Marketing authorisation holders (MAHs) and national competent authorities (NCAs) can access the platform via the link below:
MAHs and NCAs need to have an active EMA user account and an ESMP user role to sign in.
User guides for MAHs and NCAs are available with step-by-step instructions. Find them in the platform and in the 'Guidance and training materials' section on this webpage.
Select the expandable panel below to find trainings with information on how to set up ESMP user roles for MAHs and NCAs.
- European Shortages Monitoring Platform (ESMP) training session on routine shortage reporting for marketing authorisation holders of centrally authorised products (CAPs) (20/11/2024)
- European Shortages Monitoring Platform (ESMP) training on crisis and MSSG-led preparedness reporting for marketing authorisation holders (MAHs) (19/02/2025)
- EU Network Training Centre (EU NTC) course for NCAs about the platform (login required)
Guidance and training materials
Guidance and training materials to support ESMP stakeholders in the adoption and use of the platform are available.
EMA updates these documents on a regular basis and their content reflects the status at the time of publication.
To find high-level information on the platform, including how it works, reporting requirements for marketing authorisation holders (MAHs) and national competent authorities (NCAs), and how it can support EMA on human medicine shortages, see:
Training for MAHs
EMA makes available training materials for MAHs.
EMA also offers recordings of previous trainings for MAHs. These include demonstrations of the platform's functionalities, including:
- how to submit a shortage of a centrally authorised product in normal circumstances and update the submission;
- how to report in crises and MSSG-led preparedness actions.
Select the expandable panels below to access the training materials and the links to the recordings.
To find specific content in a training recording, e.g. shortage management in the EU, the overview of the ESMP, specific ESMP functionalities and reporting processes, hover your mouse over the video timeline.
Alternatively, open the video on YouTube and refer to the timestamps in the description
- European Shortages Monitoring Platform (ESMP) workshop on application programming interface (API) for marketing authorisation holders (MAHs) (24/03/2025)
- European Shortages Monitoring (ESMP) Question and answer clinic for marketing authorisation holders on shortage reporting via ESMP (25/02/2025)
- European Shortages Monitoring Platform (ESMP) training on crisis and MSSG-led preparedness reporting for marketing authorisation holders (MAHs) (19/02/2025)
- European Shortages Monitoring Platform (ESMP) training session on routine shortage reporting for marketing authorisation holders of CAPs (20/11/2024)
- European Shortages Monitoring Platform Essentials and Industry Reporting Requirements (24/06/2024)
Training for NCAs
EMA also makes available training materials and recordings of trainings to NCAs.
Select the expandable panels below to access them.
Login is required to access both trainings below.
Stakeholder engagement plan
An overview of all planned communication initiatives is available in the following document:
The plan includes initiatives up to the first quarter of 2025.
This is a living document and items may change to meet emerging needs. EMA confirms and communicates dates closer to each initiative.
Events
Throughout 2024 and 2025, EMA organises events to familiarise relevant stakeholders with the platform.
Select the expandable panel below to find a list of event pages related to ESMP, including video recordings of past events.
- European shortages monitoring platform (ESMP): updates and question and answer (Q&A) clinic for marketing authorisation holders (MAHs) (24/06/2025)
- European Shortages Monitoring Platform (ESMP) workshop on application programming interface (API) for marketing authorisation holders (MAHs) (24/03/2025)
- European Shortages Monitoring (ESMP) - Question and answer clinic for marketing authorisation holders on shortage reporting via ESMP (25/02/2025)
- European Shortages Monitoring Platform (ESMP) training on crisis and MSSG-led preparedness reporting for marketing authorisation holders (MAHs) (19/02/2025)
- European Shortages Monitoring Platform (ESMP) training session on routine shortage reporting for marketing authorisation holders of CAPs (20/11/2024)
- European Shortages Monitoring Platform Essentials and Industry Reporting Requirements (24/06/2024)
EMA carries out public system demonstrations - or demos - to inform and involve stakeholders in the development of the European Shortages Monitoring Platform (ESMP).
Select the expandable panel below for information on how to access the related video recordings.
To find video recordings select the related event pages linked in the table below.
Demo event | Functionalities showcased | Video recording timestamp |
Quarterly system demo – Q3 2024 (18/09/2024) |
| 00:05:45 |
Quarterly system demo - Q2 2024 (26/06/2024) |
| 00:25:22 |
Quarterly system demo - Q1 2024 (26/03/2024) |
| 03:01:45 |
Quarterly system demo - Q3 2023 (21/09/2023) |
| 00:26:24 |
Quarterly system demo - Q1 2023 (22/03/2023) | Data elements and upload for MAH bulk submission of shortage information | 2:17:20 |
Quarterly system demo - Q3 2022 (28/09/2022) | MAH submission of individual shortages (functionality obsolete) | 1:08:53 |
Described functionalities may change over time as the development process is gradual and iterative.
For information on other events featuring the ESMP, please search via keywords ('ESMP' or 'European shortages monitoring platform') in the events section on EMA's corporate website. There you can look for both upcoming and past events:
Development and milestones of platform
EMA is developing the platform in line with the Scaled Agile Framework (SAFe).
Following an Agile approach means that the platform will start with basic features and EMA will gradually add more over time.
EMA will keep stakeholders up-to-date on the platform's development with informative sessions, technical guidance and public demonstrations.
For more information on SAFe at EMA, see:
The timeline below highlights the key ESMP-related developments and milestones, from the adoption of legislation requiring the platform to the availability of the first version of the platform.
Development and milestones timeline
Adoption of Regulation (EU) 2022/123
First quarter of 2022
Registration of industry single point of contact (i-SPOC) for medicine supply and availability
Third quarter of 2022
For more information on iSPOCs, see Industry contact points for supply and availability of critical medicines.
IT developments and enhancements
From fourth quarter of 2022 to the first quarter of 2025
Development of functionalities for marketing authorisation holders (MAH)
From fourth quarter of 2022 to the first quarter of 2025
Development of functionalities for national competent authorities (NCA)
From first quarter of 2024 to the first quarter of 2025
Interoperability with NCA and MAH systems
From first quarter of 2024 to at least the first quarter of 2025
From implementation plan agreement to deployment
Launch of the first functionalities for routine shortage reporting of CAPs for MAH
28 November 2024
Launch of the first full version of the platform
The first full version includes all the functionalities for MAHs and NCAs, and a public page
29 January 2025
Continuous improvements and enhancements of the platform
From 2025
Interoperability with national and pharmaceutical industry systems
EMA designed the platform with interoperability as a core principle, in line with the European Commission's Interoperability Framework.
The platform's interoperability with the systems from national competent authorities (NCAs) and marketing authorisation holders (MAHs) ensures that data can be easily exchanged between these systems.
This helps harmonise and simplify monitoring and reporting on medicine shortages in the EU.
The platform also uses structured data and controlled terms from Substance, Product, Organisation and Referential (SPOR) master data to ensure consistent reporting and convergence between systems.
For more information on SPOR, see:
For NCAs and MAHs who already store their data within their internal systems, the platform enables data extraction and direct upload into it. They can still manually submit data through the ESMP interface.
Automation of data submission
EMA is developing a machine-to-machine communication interface to further enhance interoperability and streamline data submission from NCAs and MAHs.
EMA has established a set of rules and protocols to define the framework for stakeholders' systems to interact and share data with the platform. This is also known as an application programming interface (API).
A document describing the API specifications for MAHs and NCAs is available below.
Implementation timeline for the API
An implementation timeline is available below for the API.
Definition of technical formats and implementation plan
First quarter of 2024
Detailing of data fields and formats, creation of guidance materials
Second and third quarter of 2024
Start of machine-to-machine solution implementation
Fourth quarter of 2024
First data set available in machine-to-machine solution
First quarter of 2025
Frequently asked questions
Marketing authorisation holders and national competent authorities can find answers to their most frequently asked questions in the document below:
Contacts
For general questions related to the platform, get in contact through our AskEMA portal:
To get technical support, please contact us via ServiceNow: